Clinical Trial Update: Dalteparin in Preventing DVT in Participants With Cancer [NA]

View source ↗

Summary

Clinical trial update for dalteparin in preventing DVT in cancer patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Femur Fracture
• Lymphoma
• Neoplasm
• Pathologic Fracture
• Plasma Cell Myeloma
• Soft Tissue Sarcoma

Drugs mentioned

• Dalteparin (dalteparin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bone Sarcoma, Femur Fracture | NA | Status: COMPLETED | Results posted: 2021-01-22